Loading...
XSHE
000705
Market cap475mUSD
Dec 05, Last price  
10.06CNY
1D
0.90%
1Q
7.36%
Jan 2017
-23.03%
Name

Zhejiang Zhenyuan Share Co Ltd

Chart & Performance

D1W1MN
XSHE:000705 chart
P/E
96.79
P/S
0.90
EPS
0.10
Div Yield, %
0.60%
Shrs. gr., 5y
0.78%
Rev. gr., 5y
2.90%
Revenues
3.74b
-8.91%
880,572,204908,433,631954,582,9101,112,773,6041,276,037,7011,503,278,7151,719,497,2441,812,211,1152,018,147,6452,081,233,1402,163,505,5482,440,003,8922,577,916,0462,858,058,6263,243,149,4113,439,840,4403,612,045,2554,145,479,3054,106,371,5953,740,688,470
Net income
35m
-57.46%
5,295,7567,763,1597,729,82412,244,51817,791,33021,072,40531,536,13347,672,70264,438,12439,078,85836,225,61645,275,57761,082,49070,884,105211,570,67889,392,93477,295,07077,909,26581,642,56634,729,260
CFO
76m
-16.21%
28,940,50748,743,35248,384,36331,792,46026,217,24149,076,3800126,488,86217,390,49781,407,56756,744,630115,993,13351,721,83225,488,980118,359,124154,814,64075,165,175090,819,92876,095,427
Dividend
Jun 07, 20240.06 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Zhejiang Zhenyuan Share Co., Ltd. operates as a pharmaceutical company in China and internationally. It offers Chinese patent medicines, Chinese medicinal materials, Chinese herbal medicines, chemical preparations, chemical raw materials, biochemical drugs, anesthetics, psychotropic drugs, medical devices, chemical reagents, etc. The company offers its products under the Zhenyuan and Zhenyuantang brands. It serves pharmaceutical commerce and health service industries. The company was founded in 1752 and is based in Shaoxing, China.
IPO date
Apr 10, 1997
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT